We use cookies for a better user experience. Read our Privacy Policy

I Agree

Pharmaceutical Contract Sales Outsourcing [CSO] Market Trends, 2021-2031

Pharmaceutical Contract Sales Outsourcing [CSO] Market (Service: Personal Promotion, Non-personal Promotion, and Others; Therapeutic Area: Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

CSO Significant in Generating Clients amid COVID-19 Pandemic

With the coronavirus outbreak dominating global news over several months, the pharmaceutical industry has come under spotlight to increase the production capabilities in vaccines and other effective treatment options. Stakeholders in the pharmaceutical contract sales outsourcing (CSO) market are taking advantage of these developments to meet the demand of consumers and healthcare facilities. The growing awareness about enhancing the immune system is another key driver generating revenue opportunities for stakeholders in the pharmaceutical contract sales outsourcing (CSO) market during the ongoing pandemic.

In order to adapt to changing market sentiments, an increasing number of pharmaceutical companies is looking to outsource contract manufacturing organizations (CMOs). Thus, CSO plays an important role in generating prospects, nurturing leads, and moving clients through the sales pipeline. Health-related product sales have been soaring as the virus started to take hold.

pharmaceutical contract sales outsourcing cso market infographic

To know the scope of our report Get a Sample on Pharmaceutical Contract Sales Outsourcing [CSO] Market

Contract Intelligence Platforms Help Improve Supplier Relations, Clinical Trails

The pharmaceutical contract sales outsourcing (CSO) market is projected to expand at a favorable CAGR of ~7% during the assessment period. However, pharmaceutical firms are still warming up to the idea of outsourcing. Established companies who are witnessing an increased demand for products are opting for outsourcing to meet the needs of end users.

Pharmaceutical and biotech companies are presently grappling with complex drug trials, highly regulated promotional programs, and complex supply chains. Hence, companies in the pharmaceutical contract sales outsourcing (CSO) market are stepping in to provide unique platforms that streamline the operations. The Icertis Contract Intelligence (ICI) platform is being publicized for the same and has been preferred by Sanofi to accelerate drug trials whilst facilitating compliance in a tightly regulated environment. Such platforms are revolutionizing procurement contracting processes that result in improving supplier relations.

Get a glimpse of the in-depth analysis through our Report Brochure

Part-time Contract Sales Teams Hold Potential to Reduce Business Risk

The pharmaceutical contract sales outsourcing (CSO) market is expected to reach US$ 14.7 Bn by 2031. The growing expectations of pharmaceutical manufacturers from contract sales companies involve saving time and effort on recruitment, building the sales team quickly, and reducing the sales team overhead. Thus, to achieve this, sales companies are attracting qualified medical sales representatives, networking with different contacts, and using a part-time contract sales team.

There is a need for reducing business risk among pharmaceutical manufacturers. Companies in the pharmaceutical contract sales outsourcing (CSO) market are gaining awareness and establishing part-time contract sales teams that eliminate the need to invest in and maintain a permanent infrastructure. Pharma companies are willing to see the CSO’s experience in the medical sales industry before agreeing to the contract.

Leveraging Outsourced Sales Teams Facilitates in Meeting New Sales Target

Pharmaceutical companies are leveraging outsourced sales teams. Apart from time and money savings of using outsourced sales services, pharmaceutical manufacturers are turning to outsource their sales processes, simply to minimize their management burden. Such trends are translating into revenue opportunities for stakeholders in the pharmaceutical contract sales outsourcing (CSO) market. Advantages of leveraging outsourced sales teams such as instant access to a large talent pool, cost savings on staff management, and flexibility in operations are grabbing the attention of pharma companies.

Outsourced sales services provide access to exclusive sales and customer relationship management tools. Companies in the pharmaceutical contract sales outsourcing (CSO) market are providing fresh strategic insight to help pharma companies gain a competitive edge over other manufacturers. Onboarding fresh outside talent to manage sales processes can provide a pharma company new insights on meeting new sales goals.

pharmaceutical contract sales outsourcing cso market segmentation

Expanding operations in future? To get the perfect launch ask for a custom report

Analysts’ Viewpoint

Stakeholders in the pharmaceutical contract sales outsourcing (CSO) market are working with pharma customers who are in need of products more urgently than others during the COVID-19 outbreak. The growing number of biologics in development is driving the demand for high-tech development and manufacturing solutions. However, most biologics are complex and cannot be fully distinguished by science alone. Hence, companies are increasing their R&D to develop contract intelligence platforms, which help to accelerate drug trials in highly regulated promotional programs. These platforms help to reduce risk by improving visibility into compliance requirements and other obligations. The state-of-the-art technology can be a key differentiator in medical sales negotiations.

Pharmaceutical Contract Sales Outsourcing (CSO) Market: Overview

  • This report analyzes the current and future prospects of the global pharmaceutical contract sales outsourcing (CSO) market. Significant expenditure on research & development and surge in number of pharmaceutical companies are the key factors projected to fuel the growth of the global pharmaceutical contract sales outsourcing (CSO) market during the forecast period.
  • The report provides an elaborate executive summary, which comprises a snapshot of the various segments of the global pharmaceutical contract sales outsourcing (CSO) market. The report also provides information and data analysis of the global pharmaceutical contract sales outsourcing (CSO) market about segments based on service, therapeutic area, and region.
  • The overview section of the report provides detailed qualitative analysis of drivers and restraints affecting the global pharmaceutical contract sales outsourcing (CSO) market, along with opportunities in the global market
  • The global pharmaceutical contract sales outsourcing (CSO) market report includes company profiles and competitive matrix, which provide data about their businesses, product portfolios, and competitive landscape in the global pharmaceutical contract sales outsourcing (CSO) market
  • The report includes data analysis on the global pharmaceutical contract sales outsourcing (CSO) market attractiveness by region and segments
  • The last section of the report provides quantitative and qualitative analysis on market share of key players operating in the global pharmaceutical contract sales outsourcing (CSO) market. It elaborates on the key competitive strategies adopted by the major industry players, thereby presenting a thorough understanding of the competitive scenario in the global pharmaceutical contract sales outsourcing (CSO) market.

Pharmaceutical Contract Sales Outsourcing (CSO) Market: Key Segments

  • In terms of service, the global pharmaceutical contract sales outsourcing (CSO) market has been classified into personal promotion, non-personal promotion, and others
  • The personal promotion segment has been split into promotional sales team, key account management, and vacancy management
  • The non-personal promotion segment has been segregated into tele-detailing, interactive e-detailing, customer service, medical science liaisons, patient engagement services, and others
  • Based on therapeutic area, the global pharmaceutical contract sales outsourcing (CSO) market has been categorized into cardiovascular disorders, oncology, metabolic disorders, neurology, orthopedic diseases, infectious diseases, and others
  • The market size and forecast for each of these segments have been provided from 2017 to 2031. The CAGR of respective segment has also been provided for the forecast period from 2021 to 2031, considering 2020 as the base year.

Pharmaceutical Contract Sales Outsourcing (CSO) Market: Regional Outlook

  • In terms of region, the global pharmaceutical contract sales outsourcing (CSO) market has been segmented into North America (U.S. and Canada), Europe (U.K., Germany, Spain, Italy, France, and Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, and Rest of Middle East & Africa)
  • The report provides market size and forecast for each region and country/sub-region from 2017 to 2031. Compound annual growth rate (CAGR) of each of these regions and countries have also been provided for the forecast period from 2021 to 2031, considering 2020 as the base year. The pharmaceutical contract sales outsourcing (CSO) market study also covers the competitive scenario in these regions.

Companies Mentioned in Report

  • Leading players in the global pharmaceutical contract sales outsourcing (CSO) market have been profiled based on key aspects such as company overview, product portfolio, financial overview, recent developments, and competitive business strategies
  • Major companies profiled in the global pharmaceutical contract sales outsourcing (CSO) market report are
    • Ashfield (UDG Healthcare plc)
    • inVentiv Health, Inc. (Syneos Health)
    • IQVIA
    • Granard Pharmaceutical Sales & Marketing
    • Vanguard Pharma, Inc.
    • GTS Solution
    • EVERSANA
    • MaBiCo
    • QFR Solutions
    • Pharmaforce Ireland Ltd.
    • Sales Focus, Inc.
    • Amplity Health
    • PharmaLex GmbH

Pharmaceutical Contract Sales Outsourcing (CSO) Market – Segmentation

Service
  • Personal Promotion
    • Promotional Sales Team
      • Dedicated Sales Team
      • Syndicated Sales Team
    • Key Account Management
    • Vacancy Management
  • Non-personal Promotion
    • Tele-detailing
    • Interactive E-detailing
    • Customer Service
    • Medical Science Liaisons
    • Patient Engagement Services
    • Others
  • Others
Therapeutic Area
  • Cardiovascular Disorders
  • Oncology
  • Metabolic Disorders
  • Neurology
  • Orthopedic Diseases
  • Infectious Diseases
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Pharmaceutical Contract Sales Outsourcing [CSO] Market Trends, 2021-2031

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of pharmaceutical contract sales outsourcing [CSO] market?

Pharmaceutical contract sales outsourcing (CSO) market is expected to reach US$ 14.7 Bn by 2031

What is the anticipated CAGR of the pharmaceutical contract sales outsourcing [CSO] market in the forecast period?

Pharmaceutical contract sales outsourcing [CSO] market is projected to expand at a favorable CAGR of ~7% from 2021 to 2031

What are the key driving factors for the growth of the pharmaceutical contract sales outsourcing [CSO] market?

Pharmaceutical contract sales outsourcing [CSO] market is driven by increase in R&D and other operating costs in pharmaceutical industries induces medium and large pharmaceutical companies to outsource their sales operations

Which region is expected to project the highest market share in the global pharmaceutical contract sales outsourcing [CSO] market?

North America is expected to account for a significant share of the global pharmaceutical contract sales outsourcing (CSO) market during the forecast period

Which is the rising prominent segment in the pharmaceutical contract sales outsourcing [CSO] market?

The personal promotion segment dominated the global pharmaceutical contract sales outsourcing [CSO] market

Who are the key players in the global pharmaceutical contract sales outsourcing [CSO] market?

Key players operating in the global pharmaceutical contract sales outsourcing (CSO) market include Ashfield (UDG Healthcare plc), inVentiv Health, Inc. (Syneos Health), IQVIA, Granard Pharmaceutical Sales & Marketing, Vanguard Pharma, Inc., GTS Solution, EVERSANA

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Pharmaceutical Contract Sales Outsourcing (CSO) Market

4. Market Overview

    4.1. Introduction

        4.1.1. Market Introduction

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecast, 2017–2031

5. Key Insights

    5.1. Healthcare Industry Overview

    5.2. Impact of Sunshine Act on Contract Sales

    5.3. COVID-19 Pandemics Impact on Industry (Value Chain and Short /Mid / Long Term Impact)

6. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecast, by Service

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Service, 2017–2031

        6.3.1. Personal Promotion

            6.3.1.1. Promotional Sales Team

                6.3.1.1.1. Dedicated Sales Team

                6.3.1.1.2. Syndicated Sales Team

            6.3.1.2. Key Account Management

            6.3.1.3. Vacancy Management

        6.3.2. Non-personal Promotion

            6.3.2.1. Tele-detailing

            6.3.2.2. Interactive E-detailing

            6.3.2.3. Customer Service

            6.3.2.4. Medical Science Liaisons

            6.3.2.5. Patient Engagement Services

            6.3.2.6. Others

        6.3.3. Other Services

    6.4. Market Attractiveness Analysis, by Service

7. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecast, by Therapeutic Area

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Therapeutic Area, 2017–2031

        7.3.1. Cardiovascular Disorders

        7.3.2. Oncology

        7.3.3. Metabolic Disorders

        7.3.4. Neurology

        7.3.5. Orthopedic Diseases

        7.3.6. Infectious Diseases

        7.3.7. Others

    7.4. Market Attractiveness Analysis, by Therapeutic Area

8. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecast, by Region

    8.1. Key Findings

    8.2. Market Value Forecast, by Region

        8.2.1. North America

        8.2.2. Europe

        8.2.3. Asia Pacific

        8.2.4. Latin America

        8.2.5. Middle East & Africa

    8.3. Market Attractiveness Analysis, by Country/Region

9. North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. Market Value Forecast, by Service, 2017–2031

        9.2.1. Personal Promotion

            9.2.1.1. Promotional Sales Team

                9.2.1.1.1. Dedicated Sales Team

                9.2.1.1.2. Syndicated Sales Team

            9.2.1.2. Key Account Management

            9.2.1.3. Vacancy Management

        9.2.2. Non-personal Promotion

            9.2.2.1. Tele-detailing

            9.2.2.2. Interactive E-detailing

            9.2.2.3. Customer Service

            9.2.2.4. Medical Science Liaisons

            9.2.2.5. Patient Engagement Services

            9.2.2.6. Others

        9.2.3. Other Services

    9.3. Market Value Forecast, by Therapeutic Area, 2017–2031

        9.3.1. Cardiovascular Disorders

        9.3.2. Oncology

        9.3.3. Metabolic Disorders

        9.3.4. Neurology

        9.3.5. Orthopedic Diseases

        9.3.6. Infectious Diseases

        9.3.7. Others

    9.4. Market Value Forecast, by Country, 2017–2031

        9.4.1. U.S.

        9.4.2. Canada

    9.5. Market Attractiveness Analysis

        9.5.1. By Service

        9.5.2. By Therapeutic Area

        9.5.3. By Country

10. Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Service, 2017–2031

        10.2.1. Personal Promotion

            10.2.1.1. Promotional Sales Team

                10.2.1.1.1. Dedicated Sales Team

                10.2.1.1.2. Syndicated Sales Team

            10.2.1.2. Key Account Management

            10.2.1.3. Vacancy Management

        10.2.2. Non-personal Promotion

            10.2.2.1. Tele-detailing

            10.2.2.2. Interactive E-detailing

            10.2.2.3. Customer Service

            10.2.2.4. Medical Science Liaisons

            10.2.2.5. Patient Engagement Services

            10.2.2.6. Others

        10.2.3. Other Services

    10.3. Market Value Forecast, by Therapeutic Area, 2017–2031

        10.3.1. Cardiovascular Disorders

        10.3.2. Oncology

        10.3.3. Metabolic Disorders

        10.3.4. Neurology

        10.3.5. Orthopedic Diseases

        10.3.6. Infectious Diseases

        10.3.7. Others

    10.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        10.4.1. Germany

        10.4.2. U.K.

        10.4.3. France

        10.4.4. Spain

        10.4.5. Italy

        10.4.6. Rest of Europe

    10.5. Market Attractiveness Analysis

        10.5.1. By Service

        10.5.2. By Therapeutic Area

        10.5.3. By Country/Sub-region

11. Asia Pacific Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Service, 2017–2031

        11.2.1. Personal Promotion

            11.2.1.1. Promotional Sales Team

                11.2.1.1.1. Dedicated Sales Team

                11.2.1.1.2. Syndicated Sales Team

            11.2.1.2. Key Account Management

            11.2.1.3. Vacancy Management

        11.2.2. Non-personal Promotion

            11.2.2.1. Tele-detailing

            11.2.2.2. Interactive E-detailing

            11.2.2.3. Customer Service

            11.2.2.4. Medical Science Liaisons

            11.2.2.5. Patient Engagement Services

            11.2.2.6. Others

        11.2.3. Other Services

    11.3. Market Value Forecast, by Therapeutic Area, 2017–2031

        11.3.1. Cardiovascular Disorders

        11.3.2. Oncology

        11.3.3. Metabolic Disorders

        11.3.4. Neurology

        11.3.5. Orthopedic Diseases

        11.3.6. Infectious Diseases

        11.3.7. Others

    11.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        11.4.1. China

        11.4.2. Japan

        11.4.3. India

        11.4.4. Australia & New Zealand

        11.4.5. Rest of Asia Pacific

    11.5. Market Attractiveness Analysis

        11.5.1. By Service

        11.5.2. By Therapeutic Area

        11.5.3. By Country/Sub-region

12. Latin America Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Service, 2017–2031

        12.2.1. Personal Promotion

            12.2.1.1. Promotional Sales Team

                12.2.1.1.1. Dedicated Sales Team

                12.2.1.1.2. Syndicated Sales Team

            12.2.1.2. Key Account Management

            12.2.1.3. Vacancy Management

        12.2.2. Non-personal Promotion

            12.2.2.1. Tele-detailing

            12.2.2.2. Interactive E-detailing

            12.2.2.3. Customer Service

            12.2.2.4. Medical Science Liaisons

            12.2.2.5. Patient Engagement Services

            12.2.2.6. Others

        12.2.3. Other Services

    12.3. Market Value Forecast, by Therapeutic Area, 2017–2031

        12.3.1. Cardiovascular Disorders

        12.3.2. Oncology

        12.3.3. Metabolic Disorders

        12.3.4. Neurology

        12.3.5. Orthopedic Diseases

        12.3.6. Infectious Diseases

        12.3.7. Others

    12.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.4.1. Brazil

        12.4.2. Mexico

        12.4.3. Rest of Latin America

    12.5. Market Attractiveness Analysis

        12.5.1. By Service

        12.5.2. By Therapeutic Area

        12.5.3. By Country/Sub-region

13. Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Service, 2017–2031

        13.2.1. Personal Promotion

            13.2.1.1. Promotional Sales Team

                13.2.1.1.1. Dedicated Sales Team

                13.2.1.1.2. Syndicated Sales Team

            13.2.1.2. Key Account Management

            13.2.1.3. Vacancy Management

        13.2.2. Non-personal Promotion

            13.2.2.1. Tele-detailing

            13.2.2.2. Interactive E-detailing

            13.2.2.3. Customer Service

            13.2.2.4. Medical Science Liaisons

            13.2.2.5. Patient Engagement Services

            13.2.2.6. Others

        13.2.3. Other Services

    13.3. Market Value Forecast, by Therapeutic Area, 2017–2031

        13.3.1. Cardiovascular Disorders

        13.3.2. Oncology

        13.3.3. Metabolic Disorders

        13.3.4. Neurology

        13.3.5. Orthopedic Diseases

        13.3.6. Infectious Diseases

        13.3.7. Others

    13.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.4.1. GCC Countries

        13.4.2. South Africa

        13.4.3. Rest of Middle East & Africa

    13.5. Market Attractiveness Analysis

        13.5.1. By Service

        13.5.2. By Therapeutic Area

        13.5.3. By Country/Sub-region

14. Competition Landscape

    14.1. Market Player - Competition Matrix (by Tier and Size of companies)

    14.2. Market Share Analysis/Ranking, by Company, 2020

    14.3. Company Profiles

        14.3.1. Ashfield (UDG Healthcare plc)

            14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.1.2. Growth Strategies

            14.3.1.3. SWOT Analysis

        14.3.2. inVentiv Health, Inc. (Syneos Health)

            14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.2.2. Growth Strategies

            14.3.2.3. SWOT Analysis

        14.3.3. IQVIA

            14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.3.2. Growth Strategies

            14.3.3.3. SWOT Analysis

        14.3.4. Granard Pharmaceutical Sales & Marketing

            14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.4.2. Growth Strategies

            14.3.4.3. SWOT Analysis

        14.3.5. Vanguard Pharma, Inc.

            14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.5.2. Growth Strategies

            14.3.5.3. SWOT Analysis

        14.3.6. GTS Solution

            14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.6.2. Growth Strategies

            14.3.6.3. SWOT Analysis

        14.3.7. EVERSANA

            14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.7.2. Growth Strategies

            14.3.7.3. SWOT Analysis

        14.3.8. MaBiCo

            14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.8.2. Growth Strategies

            14.3.8.3. SWOT Analysis

        14.3.9. QFR Solutions

            14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.9.2. Growth Strategies

            14.3.9.3. SWOT Analysis

        14.3.10. Pharmaforce Ireland Ltd.

            14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.10.2. Growth Strategies

            14.3.10.3. SWOT Analysis

        14.3.11. Sales Focus, Inc.

            14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.11.2. Growth Strategies

            14.3.11.3. SWOT Analysis

        14.3.12. Amplity Health

            14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.12.2. Growth Strategies

            14.3.12.3. SWOT Analysis

List of Tables

Table 01: Healthcare Industry Overview (2019 or latest available)

Table 02: List of Pharmaceutical CSO companies by Region

Table 03: Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Service, 2017–2031

Table 04: Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Personal Promotion, 2017–2031

Table 05: Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Promotional Sales Team, 2017–2031

Table 06: Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Non-personal Promotion, 2017–2031

Table 07: Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017–2031

Table 08: Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 09: North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 10: North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Service, 2017–2031

Table 11: North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Personal Promotion, 2017–2031

Table 12: North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Promotional Sales Team, 2017–2031

Table 13: North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Non-personal Promotion, 2017–2031

Table 14: North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017–2031

Table 15: Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 16: Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Service, 2017–2031

Table 17: Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Personal Promotion, 2017–2031

Table 18: Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Promotional Sales Team, 2017–2031

Table 19: Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Non-personal Promotion, 2017–2031

Table 20: Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017–2031

Table 21: Asia Pacific Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 22: Asia Pacific Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Service, 2017–2031

Table 23: Asia Pacific Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Personal Promotion, 2017–2031

Table 24: Asia Pacific Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Promotional Sales Team, 2017–2031

Table 25: Asia Pacific Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Non-personal Promotion, 2017–2031

Table 26: Asia Pacific Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017–2031

Table 27: Latin America Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 28: Latin America Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Service, 2017–2031

Table 29: Latin America Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Personal Promotion, 2017–2031

Table 30: Latin America Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Promotional Sales Team, 2017–2031

Table 31: Latin America Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Non-personal Promotion, 2017–2031

Table 32: Latin America Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017–2031

Table 33: Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 34: Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Service, 2017–2031

Table 35: Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Personal Promotion, 2017–2031

Table 36: Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Promotional Sales Team, 2017–2031

Table 37: Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Non-personal Promotion, 2017–2031

Table 38: Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017–2031

List of Figures

Figure 01: Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Value Share, by Service, 2020

Figure 03: Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Value Share, by Therapeutic Area, 2020

Figure 04: Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Value Share, by Region, 2020

Figure 05: Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Value Share Analysis, by Service, 2020 and 2031

Figure 06: Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Attractiveness Analysis, by Service, 2021–2031

Figure 07: Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Revenue (US$ Mn), by Personal Promotion, 2017–2031

Figure 08: Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Revenue (US$ Mn), Non-personal Promotion, 2017–2031

Figure 09: Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Revenue (US$ Mn), by Others, 2017–2031

Figure 10: Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Value Share Analysis, by Therapeutic Area, 2020 and 2031

Figure 11: Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Attractiveness Analysis, by Therapeutic Area, 2021–2031

Figure 12: Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Revenue (US$ Mn), by Cardiovascular Disorders, 2017–2031

Figure 13: Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Revenue (US$ Mn), Oncology, 2017–2031

Figure 14: Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Revenue (US$ Mn), by Metabolic Disorders, 2017–2031

Figure 15: Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Revenue (US$ Mn), Neurology, 2017–2031

Figure 16: Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Revenue (US$ Mn), by Orthopedic Diseases, 2017–2031

Figure 17: Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Revenue (US$ Mn), Infectious Diseases, 2017–2031

Figure 18: Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Revenue (US$ Mn), by Others, 2017–2031

Figure 19: Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Value Share Analysis, by Region, 2020 and 2031

Figure 20: Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Attractiveness Analysis, by Region, 2021–2031

Figure 21: North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, 2017–2031

Figure 22: North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Value Share Analysis, by Country, 2020 and 2031

Figure 23: North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Attractiveness Analysis, by Country, 2021–2031

Figure 24: North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Value Share Analysis, by Service, 2020 and 2031

Figure 25: North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Attractiveness Analysis, by Service, 2021–2031

Figure 26: North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Value Share Analysis, by Therapeutic Area, 2020 and 2031

Figure 27: North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Attractiveness Analysis, by Therapeutic Area, 2021–2031

Figure 28: Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, 2017–2031

Figure 29: Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 30: Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 31: Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Value Share Analysis, by Service, 2020 and 2031

Figure 32: Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Attractiveness Analysis, by Service, 2021–2031

Figure 33: Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Value Share Analysis, by Therapeutic Area, 2020 and 2031

Figure 34: Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Attractiveness Analysis, by Therapeutic Area, 2021–2031

Figure 35: Asia Pacific Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, 2017–2031

Figure 36: Asia Pacific Pharmaceutical Contract Sales Outsourcing (CSO) Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 37: Asia Pacific Pharmaceutical Contract Sales Outsourcing (CSO) Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 38: Asia Pacific Pharmaceutical Contract Sales Outsourcing (CSO) Market Value Share Analysis, by Service, 2020 and 2031

Figure 39: Asia Pacific Pharmaceutical Contract Sales Outsourcing (CSO) Market Attractiveness Analysis, by Service, 2021–2031

Figure 40: Asia Pacific Pharmaceutical Contract Sales Outsourcing (CSO) Market Value Share Analysis, by Therapeutic Area, 2020 and 2031

Figure 41: Asia Pacific Pharmaceutical Contract Sales Outsourcing (CSO) Market Attractiveness Analysis, by Therapeutic Area, 2021–2031

Figure 42: Latin America Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, 2017–2031

Figure 43: Latin America Pharmaceutical Contract Sales Outsourcing (CSO) Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 44: Latin America Pharmaceutical Contract Sales Outsourcing (CSO) Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 45: Latin America Pharmaceutical Contract Sales Outsourcing (CSO) Market Value Share Analysis, by Service, 2020 and 2031

Figure 46: Latin America Pharmaceutical Contract Sales Outsourcing (CSO) Market Attractiveness Analysis, by Service, 2021–2031

Figure 47: Latin America Pharmaceutical Contract Sales Outsourcing (CSO) Market Value Share Analysis, by Therapeutic Area, 2020 and 2031

Figure 48: Latin America Pharmaceutical Contract Sales Outsourcing (CSO) Market Attractiveness Analysis, by Therapeutic Area, 2021–2031

Figure 49: Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Value (US$ Mn) Forecast, 2017–2031

Figure 50: Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 51: Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 52: Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Value Share Analysis, by Service, 2020 and 2031

Figure 53: Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Attractiveness Analysis, by Service, 2021–2031

Figure 54: Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Value Share Analysis, by Therapeutic Area, 2020 and 2031

Figure 55: Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Attractiveness Analysis, by Therapeutic Area, 2021–2031

Figure 56: Global Pharmaceutical Contract Sales Outsourcing (CSO) Market: Company Share Analysis, 2020

Figure 57: UDG Healthcare plc - Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2020

Figure 58: UDG Healthcare plc - Breakdown of Net Sales (%), by Region/Country, 2020

Figure 59: UDG Healthcare plc - Breakdown of Net Sales (%), by Business Segment, 2020

Figure 60: Ashfield - Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2020

Figure 61: Syneos Health - Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2019

Figure 62: Syneos Health - Breakdown of Net Sales (%), by Region/Country, 2019

Figure 63: Syneos Health - Breakdown of Net Sales (%), by Business Segment, 2019

Figure 64: IQVIA Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2020

Figure 65: IQVIA Breakdown of Net Sales (%), by Region/Country, 2020

Figure 66: IQVIA Breakdown of Net Sales (%), by Business Segment, 2020

Figure 67: IQVIA Contract Sales & Medical Solutions Segment Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2020

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

594

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved